Posted on 09/09/2024 7:08:38 AM PDT by Red Badger
Test tubes labelled "Monkeypox virus positive and negative" are seen in this illustration taken May 23, 2022. [Photo/Agencies]
=================================================================
A domestic monkeypox vaccine candidate developed by Chinese drugmaker Sinopharm received clearance from the top drug regulator for clinical trials on Monday, representing the nation's first experimental dose to win the trial approval, said the company.
The vaccine candidate is created by Shanghai Institute of Biological Products administered by Sinopharm and is expected to play an important role in preventing and controlling monkeypox infections, said the company in a statement released on Monday afternoon.
In China, a vaccine candidate typically goes through three phases of clinical trials before gaining a market approval. The process can take years and even decades, but the National Medical products Administration, China's top drug regulator, has launched a number of accelerated or streamlined channels to facilitate applications of novel drugs and vaccines or those in urgent need.
According to the company, the new drug is a replication-deficient vaccine based on a strain called MVA. The description is the same as Jynneos, the world's first monkeypox vaccine approved by the Food and Drug Administration in the United States in 2019.
The company said it has accumulated rich data on the vaccine's safety and efficacy through preclinical studies and production methods for the vaccine are deemed reliable and stable.
"In nonhuman primate models, the vaccine can generate good immune protection against monkeypox virus," it said.
There is currently no approved monkeypox vaccine in China. Globally, a few vaccines have been approved in the United States, Canada, the European Union, Japan and Russia.
The World Health Organization said on Aug 14 that the monkeypox outbreak in Africa constitutes a public health emergency of international concern — its highest form of alert.
Previously in July 2022, the WHO declared a global emergency but then lifted in May 2023 because of a sustained decline in international cases.
So far, more than 120 countries and regions across the world have reported over 100,000 confirmed infections and 226 related deaths.
China classified monkeypox as a Class B infectious disease — on par with COVID-19 and AIDS — in September of last year.
The nation reported the first imported case in September 2022 and the first domestic case in June 2023.
As of the end of July, China reported 2,567 confirmed cases.
Like I’m going to trust a vaccine made in China?
Nope.
I’ll take my chances with the virus...
And just in time for the 2024 election
Don’t bend over.
Works better than the vaccine.
Avoiding infection is simply a lifestyle choice. Its weird how they stopped talking about the rate of infections among children and domestic pets after people started talking about how its transmitted....
This disease is primarily transmitted by homo men engaging in anal sex.
Just like AIDS. Which means most of the population is at zero risk.
BOHICA!........................
Don’t get shot. The gun doesn’t make any noise, but it can kill you.
We are doing anything so some men can engage in buggery....
Wow, can’t wait for that one... : /
Yeah, ain't it?
The risk factors are known, not any group I'm in, I'll take my chances...
Low intensity, time bomb bio warfare
EXACTLY!!!!!
Made in China and I’m supposed to inject it into my body?????
No way in hell.
There is two Clades and three dominate strains circulating today. You are mostly right that the Mpox from last year was almost entirely an STD that is a Clade II strain it’s still here and in Europe and Africa. What’s new is there is a brand new Claude Ib strain that’s a completely different virus and its running rampant in 15 countries in Africa 75% those infected with Clade Ib are children under 18 and 6}% are under 15. Clade I and Ib are not STD obviously school aged children are not doing mass gaystuff orgys in Africa. Any article of clothing that touches a infected persons sores then becomes a contact vector Clade I doesn’t need broken skin it’s like herpes simplex it can cross the intact skin barrier. So don’t pat yourself on the back just yet if Clade I or Ib gets a foothold in a modern density populated area it can and will spread without sexual contact. It’s one thing to ha e it in a village where kids share the same school building and that pretty much contains it to th at village. It’s quite another to have air travel spread it far and wide. Sitting in a seat after someone who is infected shedding scabs, pus and live virus attached to skin cells is a transmission vector of Clade I Mpox so is face to face droplet transmission one droplet in the eye, nose or mouth is enough. Say it don’t spray it is literally a thing then. Look up the age break down of the current DRC outbreak it’s not an STD at all.
The new Cladew Ib was first found in the Central African Republic of Congo why would Dr evil release it in back water villages in the jungle of Africa? If you were going to 12 monkeys a bioweapon you release it in a modern city right in an airport JFK or Atlanta or London Heathrow that goes pandemic that same day then. The jungles of Africa have all kind of nasties humans have never seen just waiting for some unlucky person to eat Bush meat, inhale animal waste products that dried in the corner of their huts or gets scratched or bite by a animal the means of exposure in the jungle is limitless really.
Unless you’re homosexual, you won’t have to.
Why do you believe the propaganda?
Post 13...
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.